Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1991 Jun;48(6):1154–1158.

Characterization of the molecular basis of the alpha 1-antitrypsin F allele.

H Okayama 1, M Brantly 1, M Holmes 1, R G Crystal 1
PMCID: PMC1683089  PMID: 2035534

Abstract

alpha 1-Antitrypsin (alpha 1AT), the major serum inhibitor of neutrophil elastase, is a highly polymorphic serum protein associated with characteristic isoelectric-focusing (IEF) patterns for most variants. To characterize the molecular basis of the anodal F variant, the DNA sequence of the coding exons of an FZ individual was determined. The F allele differed from the normal M1(Val213) alpha 1AT allele by a single nucleotide transversion of cytosine to thymidine, which results in the amino acid substitution Arg223 CGT----Cys TGT. Inheritance of the F mutation was confirmed by family analysis using allele-specific amplification. In the context that the normal alpha 1AT molecule has only one cysteine residue, a mutation resulting in the addition of a second cysteine may influence the three-dimensional form of the protein and/or permit interaction with other plasma proteins with free-SH groups and may be responsible for the observation that the major F alpha 1AT bands often migrate as doublets in IEF gels.

Full text

PDF
1154

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckman G., Stjernberg N. L., Eklund A. Is the PiF allele of alpha 1-antitrypsin associated with pulmonary disease? Clin Genet. 1984 Jun;25(6):491–495. [PubMed] [Google Scholar]
  2. Billingsley G. D., Cox D. W. Functional assessment of genetic variants of alpha 1-antitrypsin. Hum Genet. 1982;61(2):118–122. doi: 10.1007/BF00274200. [DOI] [PubMed] [Google Scholar]
  3. Boutin B., Feng S. H., Arnaud P. The genetic polymorphism of alpha 2-HS glycoprotein: study by ultrathin-layer isoelectric focusing and immunoblot. Am J Hum Genet. 1985 Nov;37(6):1098–1105. [PMC free article] [PubMed] [Google Scholar]
  4. Carrell R. W., Jeppsson J. O., Laurell C. B., Brennan S. O., Owen M. C., Vaughan L., Boswell D. R. Structure and variation of human alpha 1-antitrypsin. Nature. 1982 Jul 22;298(5872):329–334. doi: 10.1038/298329a0. [DOI] [PubMed] [Google Scholar]
  5. Cockcroft D. W., Tennent R. K., Horne S. L. Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype. Can Med Assoc J. 1981 Mar 15;124(6):737–742. [PMC free article] [PubMed] [Google Scholar]
  6. Constans J., Viau M., Gouaillard C. Pi M4: an additional Pi M subtype. Hum Genet. 1980;55(1):119–121. doi: 10.1007/BF00329137. [DOI] [PubMed] [Google Scholar]
  7. Cox D. W., Johnson A. M., Fagerhol M. K. Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978. Hum Genet. 1980;53(3):429–433. doi: 10.1007/BF00287070. [DOI] [PubMed] [Google Scholar]
  8. Crystal R. G. The alpha 1-antitrypsin gene and its deficiency states. Trends Genet. 1989 Dec;5(12):411–417. doi: 10.1016/0168-9525(89)90200-x. [DOI] [PubMed] [Google Scholar]
  9. Fagerhol M. K., Braend M. Serum prealbumin: polymorphism in man. Science. 1965 Aug 27;149(3687):986–987. doi: 10.1126/science.149.3687.986. [DOI] [PubMed] [Google Scholar]
  10. Fagerhol M. K. Le système des Pi, sa génétique et ses rapports avec les maladies. Poumon Coeur. 1971;27(1):41–51. [PubMed] [Google Scholar]
  11. Graham A., Kalsheker N. A., Newton C. R., Bamforth F. J., Powell S. J., Markham A. F. Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys). Hum Genet. 1989 Dec;84(1):55–58. doi: 10.1007/BF00210671. [DOI] [PubMed] [Google Scholar]
  12. Gyllensten U. B., Erlich H. A. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7652–7656. doi: 10.1073/pnas.85.20.7652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kelly C. P., Tyrrell D. N., McDonald G. S., Whitehouse D. B., Prichard J. S. Heterozygous FZ alpha 1 antitrypsin deficiency associated with severe emphysema and hepatic disease: case report and family study. Thorax. 1989 Sep;44(9):758–759. doi: 10.1136/thx.44.9.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Loebermann H., Tokuoka R., Deisenhofer J., Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 1984 Aug 15;177(3):531–557. [PubMed] [Google Scholar]
  15. Long G. L., Chandra T., Woo S. L., Davie E. W., Kurachi K. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry. 1984 Oct 9;23(21):4828–4837. doi: 10.1021/bi00316a003. [DOI] [PubMed] [Google Scholar]
  16. Mittman C., Barbela T., Lieberman J. Antitrypsin deficiency and abnormal protease inhibitor phenotypes. Arch Environ Health. 1973 Sep;27(3):201–206. doi: 10.1080/00039896.1973.10666352. [DOI] [PubMed] [Google Scholar]
  17. Nukiwa T., Brantly M., Ogushi F., Fells G., Satoh K., Stier L., Courtney M., Crystal R. G. Characterization of the M1(Ala213) type of alpha 1-antitrypsin, a newly recognized, common "normal" alpha 1-antitrypsin haplotype. Biochemistry. 1987 Aug 25;26(17):5259–5267. doi: 10.1021/bi00391a008. [DOI] [PubMed] [Google Scholar]
  18. Nukiwa T., Satoh K., Brantly M. L., Ogushi F., Fells G. A., Courtney M., Crystal R. G. Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J Biol Chem. 1986 Dec 5;261(34):15989–15994. [PubMed] [Google Scholar]
  19. Okayama H., Curiel D. T., Brantly M. L., Holmes M. D., Crystal R. G. Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med. 1989 Aug;114(2):105–113. [PubMed] [Google Scholar]
  20. Pierce J. A., Eradio B., Dew T. A. Antitrypsin phenotypes in St. Louis. JAMA. 1975 Feb 10;231(6):609–612. [PubMed] [Google Scholar]
  21. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  22. Saiki R. K., Scharf S., Faloona F., Mullis K. B., Horn G. T., Erlich H. A., Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985 Dec 20;230(4732):1350–1354. doi: 10.1126/science.2999980. [DOI] [PubMed] [Google Scholar]
  23. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Thornton J. M. Disulphide bridges in globular proteins. J Mol Biol. 1981 Sep 15;151(2):261–287. doi: 10.1016/0022-2836(81)90515-5. [DOI] [PubMed] [Google Scholar]
  25. Wewers M. D., Casolaro M. A., Sellers S. E., Swayze S. C., McPhaul K. M., Wittes J. T., Crystal R. G. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med. 1987 Apr 23;316(17):1055–1062. doi: 10.1056/NEJM198704233161704. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES